See the list below for recent work done by our brilliant collaborators using VivoQuant for analysis.

As always, please remember to cite VivoQuant if you have used it in your research by mentioning VivoQuant (inviCRO, Boston MA). Thank you.

Park TY, Nishida KS, Wilson CM, Jaiswal S, Scott J, Hoy AR, Selwyn RG, Dardzinski BJ, Choi KH. Effects of isoflurane anesthesia and intravenous morphine self-administration on regional glucose metabolism ([18F] FDG-PET) of male Sprague-Dawley rats. European Journal of Neuroscience. 2017; 45(7): 922-931.

Jaiswal S, Hockenbury N, Meyer C, Hoy A, Dardzinski B, Byrnes K. Evaluation of Intranasal Insulin Administration on Regional Metabolic Changes in Rat Brain with Cognitive testing during Uptake using [18F] FDG PET following moderate CCI. Journal of Nuclear Medicine. 2017; 58(1): 655.

Jaiswal S, Cramer N, Scott J, Meyer C, Xu X, Whiting K, Hoy A, Galdzicki Z, Dardzinski B. [18F] FDG PET to study the effect of simulated high altitude on regional brain activity in mice. Journal of Nuclear Medicine. 2017; 58(1): 1246.

Asiedu KO, Koyasu S, Szajek LP, Choyke PL, Sato N. Bone marrow cell trafficking analyzed by 89Zr-oxine positron emission tomography in a murine transplantation model. Clinical Cancer Research. 2017; 23(11): 2759-2768.

Simion V, Sobilo J, Clemoncon R, Natkunarajah S, Ezzine S, Abdallah F, Lerondel S, Pichon C, Baril P. Positive radionuclide imaging of miRNA expression using RILES and the human sodium iodide symporter as reporter gene is feasible and supports a protective role of miRNA-23a in response to muscular atrophy. PloS One. 2017; 12(5).

Brabazon F, Wilson CM, Shukla DK, Mathur S, Jaiswal S, Bermudez S, Byrnes KR, Selwyn R. [18F] FDG-PET combined with MRI elucidates the pathophysiology of traumatic brain injury in rats. Journal of Neurotrauma. 2017; 34(5): 1074-1085.

James ML, Belichenko NP, Shuhendler AJ, Hoehne A, Andrews LE, Condon C, Nguyen TV, Reiser V, Jones P, Trigg W. [18F] GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer’s Disease. Theranostics. 2017; 7(6): 1422.

Dalm SU, Bakker IL, de Blois E, Doeswijk GN, Konijnenberg MW, i F, Barbato D, Tedesco M, Maina T, Nock BA. 68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use in oncology. Journal of Nuclear Medicine. 2017; 58(2): 293-299.

Larimer BM, Wehrenberg-Klee E, Dubois F, Mehta A, Kalomeris T, Flaherty K, G, Mahmood U. Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response. Cancer Research. 2017; 77(9): 2318-2327.

Horstmann PF, Raina D, Isaksson H, Hettwer W, Lidgren L, Petersen MM, Tägil M. Composite Biomaterial as a Carrier for Bone Active Substances for Metaphyseal Tibial Bone Defect Reconstruction in Rats. Tissue Engineering. 2017.

Qiao H, Wang Y, Zhang R, Gao Q, Liang X, Gao L, Jiang Z, Qiao R, Han D, Zhang Y. MRI/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe 3 O 4 nanoparticles. Biomaterials. 2017; 112(1): 336-345.

Li N, Yu Z, Pham TT, Blower PJ, Yan R. A generic 89Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography. International journal of nanomedicine. 2017; 12(1): 3281.

Zhang Z, Ordonez AA, Smith-Jones P, Wang H, Gogarty KR, Daryaee F, Bambarger LE, Chang YS, Jain SK, Tonge PJ. The biodistribution of 5-[18F] fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography. PloS One. 2017; 12(2).

Honarvar H, Müller C, Cohrs S, Haller S, Westerlund K, Karlström AE, van der Meulen NP, Schibli R, Tolmachev V. Evaluation of the first 44 Sc-labeled Affibody molecule for imaging of HER2-expressing tumors. Nuclear Medicine and Biology. 2017; 45(1): 15-21.

Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring MP, Helenius K, Olson BM, Pyzer AR, Wang LC. Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Anti-Tumor Innate Immunity. Cancer Discovery. 2017.

Maisonial-Besset A, Witkowski T, Navarro-Teulon I, Berthier-Vergnes O, Fois G, Zhu Y, Besse S, Bawa O, Briat A, Quintana M. Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer. Oncotarget. 2017; 8(13): 22034.

Neves AA, Xie B, Fawcett S, Alam IS, Witney TH, de Backer MM, Summers J, Hughes W, McGuire S, Soloviev D. Rapid Imaging of Tumor Cell Death in vivo using the C2A domain of Synaptotagmin-I. Journal of Nuclear Medicine. 2017.

Shteinfer-Kuzmine A, Arif T, Krelin Y, Tripathi SS, Paul A, Shoshan-Barmatz V. Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma. Oncotarget. 2017; 8(19): 31329.

Young JD, Abbate V, Imberti C, Meszaros LK, Ma MT, Terry SY, Hider RC, Mullen GE, Blower PJ. 68Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room temperature, one-step kit-based radiolabeling. Journal of Nuclear Medicine. 2017.

Macholl S, Finucane CM, Hesterman J, Mather SJ, Pauplis R, Scully D, Sosabowski JK, Jouannot E. High-throughput high-volume nuclear imaging for preclinical in vivo compound screening. EJNMMI research. 2017; 7(1): 33.

Zennami K, Zhang Y, Zhou H, Thorek D, DeWeese T, Lupold S. MP83-12 Tissue-specific radiation sensitization of prostate cancer by aptamer targeted sirna knock-down or DNA repair pathway. The Journal of Urology. 2017; 197(4).

Geyer A, Lorenzer C, Gehrig S, Simlinger M, Winkler J, Sami H, Ogris M. Fluorescence-and computed tomography for assessing the biodistribution of siRNA after intratracheal application in mice. International Journal of Pharmaceutics. 2017; 525(2): 359-366.

Hongo H, Kosaka T, Yasumizu Y, Miyazaki Y, Kikuchi E, Miyajima A, Oya M. MP83-10 Correlation between cabazitaxel resistance and emt in metastatic castration resistant prostate cancer. The Journal of Urology. 2017; 197(4): e1109–e1110.

Ramot Y, Schiffenbauer YS, Amouyal N, Ezov N, Steiner M, Izrael M, Lavon N, Hasson A, Revel M, Nyska A. Compact MRI for the detection of teratoma development following intrathecal human embryonic stem cell injection in NOD-SCID mice. NeuroToxicology. 2017.

Varga Z, Szigyártó IC, Gyurkó I, Dóczi R, Horváth I, Máthé D, Szigeti K. Radiolabeling and Quantitative In Vivo SPECT/CT Imaging Study of Liposomes Using the Novel Iminothiolane-99mTc-Tricarbonyl Complex. Contrast Media & Molecular Imaging. 2017; 2017.

Mulgaonkar A, Moeendarbari S, Silvers W, Hassan G, Sun X, Hao Y, Mao W. Hollow Gold Nanoparticles as Efficient In Vivo Radiosensitizing Agents for Radiation Therapy of Breast Cancer. Journal of Biomedical Nanotechnology. 2017; 13(5): 566-574.

Khoshnevisan A, Chuamsaamarkkee K, Boudjemeline M, Jackson A, Smith GE, Gee AD, Fruhwirth GO, Blower PJ. 18F-Fluorosulfate for PET Imaging of the Sodium–Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo. Journal of Nuclear Medicine. 2017; 58(1): 156-161.

Umbricht CA, Benesová M, Schmid RM, Türler A, Schibli R, van der Meulen NP, Müller C. 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617–preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617. EJNMMI research. 2017; 7(1): 9.

Jin J, Yurkow EJ, Adler D, Lee T. A Novel Approach To Improve the Efficiency of Block Freeze Concentration Using Ice Nucleation Proteins with Altered Ice Morphology. Journal of Agricultural and Food Chemistry. 2017.

Sarabia-Estrada R, Ruiz-Valls A, Shah SR, Ahmed AK, Ordonez AA, Rodriguez FJ, Guerrero-Cazares H, Jimenez-Estrada I, Velarde E, Tyler B. Effects of primary and recurrent sacral chordoma on the motor and nociceptive function of hindlimbs in rats: an orthotopic spine model. Journal of Neurosurgery: Spine. 2017.

Pálmai M, Petho A, Nagy LN, Klébert S, May Z, Mihály J, Wacha A, Jemnitz K, Veres Z, Horváth I. Direct immobilization of manganese chelates on silica nanospheres for MRI applications. Journal of Colloid and Interface Science. 2017; 498(1): 298-305.

Domnanich KA, Müller C, Farkas R, Schmid RM, Ponsard B, Schibli R, Türler A, van der Meulen NP. 44Sc for labeling of DOTA-and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharmacy and Chemistry. 2017.

Domnanich KA, Müller C, Benesová M, Dressler R, Haller S, Köster U, Ponsard B, Schibli R, Türler A, van der Meulen NP. 47Sc as useful β—emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes. EJNMMI Radiopharmacy and Chemistry. 2017; 2(1): 5.

Hsu M, Prigent J, Dollet P, Ravau J, Larbanoix L, Van Simaeys G, Bol A, Grégoire V, Goldman S, re G. Long-term in vivo monitoring of adult-derived human liver stem/progenitor cells by Bioluminescence Imaging, PET and contrast enhanced CT. Stem Cells and Development. 2017.